These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 19718465

  • 1. The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor.
    Verkleij CJ, Nieuwdorp M, Gerdes VE, Mörgelin M, Meijers JC, Marx PF.
    Thromb Haemost; 2009 Sep; 102(3):460-8. PubMed ID: 19718465
    [Abstract] [Full Text] [Related]

  • 2. The role of thrombin-activatable fibrinolysis inhibitor in diabetic wound healing.
    Verkleij CJ, Roelofs JJ, Havik SR, Meijers JC, Marx PF.
    Thromb Res; 2010 Nov; 126(5):442-6. PubMed ID: 20828799
    [Abstract] [Full Text] [Related]

  • 3. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [Abstract] [Full Text] [Related]

  • 4. Postprandial thrombin activatable fibrinolysis inhibitor and markers of endothelial dysfunction in type 2 diabetic patients.
    Rigla M, Wägner AM, Borrell M, Mateo J, Foncuberta J, de Leiva A, Ordóñez-Llanos J, Pérez A.
    Metabolism; 2006 Nov; 55(11):1437-42. PubMed ID: 17046544
    [Abstract] [Full Text] [Related]

  • 5. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients.
    Kitagawa N, Yano Y, Gabazza EC, Bruno NE, Araki R, Matsumoto K, Katsuki A, Hori Y, Nakatani K, Taguchi O, Sumida Y, Suzuki K, Adachi Y.
    Diabetes Res Clin Pract; 2006 Aug; 73(2):150-7. PubMed ID: 16458385
    [Abstract] [Full Text] [Related]

  • 6. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
    Yener S, Comlekci A, Akinci B, Demir T, Yuksel F, Ozcan MA, Bayraktar F, Yesil S.
    Med Princ Pract; 2009 Aug; 18(4):266-71. PubMed ID: 19494532
    [Abstract] [Full Text] [Related]

  • 7. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 8. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
    Mosnier LO, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in Type 1 diabetes: evidence for normal fibrinolytic state.
    Harmanci A, Kandemir N, Dagdelen S, Gonc N, Buyukasik Y, Alikasifoglu A, Kirazli S, Ozon A, Gurlek A.
    J Diabetes Complications; 2006 Jan; 20(1):40-4. PubMed ID: 16389166
    [Abstract] [Full Text] [Related]

  • 10. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
    Nielsen VG, Ellis TC.
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
    [Abstract] [Full Text] [Related]

  • 11. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
    Mosnier LO, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
    [Abstract] [Full Text] [Related]

  • 12. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
    Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN.
    J Clin Invest; 1997 May 15; 99(10):2323-7. PubMed ID: 9153272
    [Abstract] [Full Text] [Related]

  • 13. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO, Elisen MG, Bouma BN, Meijers JC.
    Thromb Haemost; 2001 Oct 15; 86(4):1057-64. PubMed ID: 11686324
    [Abstract] [Full Text] [Related]

  • 14. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
    Kemona-Chetnik I, Kowal K, Kucharewicz I, Pampuch A, Bodzenta-Lukaszyk A.
    Przegl Lek; 2006 Oct 15; 63(12):1281-5. PubMed ID: 17642140
    [Abstract] [Full Text] [Related]

  • 15. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M.
    Transplant Proc; 2006 Oct 15; 38(1):105-7. PubMed ID: 16504676
    [Abstract] [Full Text] [Related]

  • 16. Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation.
    Colucci M, Semeraro N.
    Thromb Res; 2012 Mar 15; 129(3):314-9. PubMed ID: 22113149
    [Abstract] [Full Text] [Related]

  • 17. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J, Hudecek J, Kubisz P.
    Vnitr Lek; 2004 Jan 15; 50(1):36-44. PubMed ID: 15015228
    [Abstract] [Full Text] [Related]

  • 18. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM, Cooper AJ, Lwaleed BA.
    Clin Chim Acta; 2007 Mar 15; 378(1-2):1-6. PubMed ID: 17184758
    [Abstract] [Full Text] [Related]

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
    Małyszko J, Małyszko JS, Hryszko T, Myśliwiec M.
    Thromb Haemost; 2004 Mar 15; 91(3):480-6. PubMed ID: 14983223
    [Abstract] [Full Text] [Related]

  • 20. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
    Nielsen VG, Steenwyk BL, Gurley WQ.
    J Heart Lung Transplant; 2006 Oct 15; 25(10):1247-52. PubMed ID: 17045938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.